About Caliper Life SciencesCaliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results, enabling the translation of those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.
The statements in this press release regarding Caliper's anticipated total revenue for the fourth quarter of 2010 and for 2010, its expectation that it will report positive non-GAAP earnings per share in the fourth quarter and on a full year basis in 2010, its expected cash position as of December 31, 2010, its expectation that it will report positive operating cash flows in the fourth quarter and on a full-year basis for 2010, and its projected revenue growth estimates for 2011 are "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those Caliper expects or projects, including the risks that unexpected information may be received, or adjustments may be made, in the course of finalizing and analyzing Caliper's financial results for the fourth quarter and for 2010, which could c
|SOURCE Caliper Life Sciences, Inc.|
Copyright©2010 PR Newswire.
All rights reserved